29th Annual North American Cystic Fibrosis Conference

W14: NT: Early Studies of Novel Small Molecule Therapies

Oct 9, 2015 2:00pm ‐ Oct 9, 2015 3:45pm

Standard: $49.99

Description

This session will consider novel small molecule therapeutic approaches directed at CF relevant drug targets, including delF508-CFTR, epithelial sodium channels & less frequent CFTR mutations. The session provides perspectives from academic & industrial laboratories.

Educational Objectives:

  1. Discuss innovative approaches to restore the expression, stability & function of delF508-CFTR.
  2. Review the challenges of developing rational new therapies for rare CF mutations.
  3. Explain the therapeutic potential for CF lung disease of small molecules that modify ENaC function.

Speaker(s):

You must be logged in and own this session in order to post comments.